A
Art Reingold
Researcher at University of California, Berkeley
Publications - 23
Citations - 1753
Art Reingold is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Population & Streptococcus pneumoniae. The author has an hindex of 15, co-authored 23 publications receiving 1416 citations.
Papers
More filters
Journal ArticleDOI
The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.
Emily J. Weston,Tracy Pondo,Melissa Lewis,Pat Martell-Cleary,Craig Morin,Brenda Jewell,Pam Daily,Mirasol Apostol,Sue Petit,Monica M. Farley,Ruth Lynfield,Art Reingold,Nellie I. Hansen,Barbara J. Stoll,Andi L. Shane,Elizabeth R. Zell,Stephanie J. Schrag +16 more
TL;DR: The burden of invasive EOS remains substantial in the era of GBS prevention and disproportionately affects preterm and black infants and Identification of strategies to prevent preterm births is needed to reduce the neonatal sepsis burden.
Journal ArticleDOI
Substantial underestimation of SARS-CoV-2 infection in the United States.
Sean L. Wu,Andrew Mertens,Yoshika S. Crider,Anna Nguyen,Nolan N Pokpongkiat,Stephanie Djajadi,Anmol Seth,Michelle S. Hsiang,John M. Colford,Art Reingold,Benjamin F. Arnold,Alan Hubbard,Jade Benjamin-Chung +12 more
TL;DR: A semi-Bayesian probabilistic bias analysis is used to correct for biased testing and imperfect diagnostic accuracy to provide a more realistic assessment of COVID-19 burden of SARS-CoV-2 infection.
Journal ArticleDOI
Risk Factors for Severe Pulmonary and Disseminated Coccidioidomycosis: Kern County, California, 1995–1996
Nancy E. Rosenstein,K W Emery,S B Werner,A Kao,Royce H. Johnson,D Rogers,Duc J. Vugia,Art Reingold,R Talbot,Brian D. Plikaytis,Bradley A. Perkins,Rana A. Hajjeh +11 more
TL;DR: Early treatment of coccidioidomycosis with oral antifungal agents may prevent severe pulmonary disease in groups considered to be at high risk, such as elderly individuals, persons with diabetes, and smokers.
Journal ArticleDOI
Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough.
Scott A. Flanders,John C. Stein,Guy Shochat,Karen Sellers,Miles Holland,Judith H. Maselli,W. Lawrence Drew,Art Reingold,Ralph Gonzales +8 more
TL;DR: C-reactive protein levels could be a valuable addition to clinical prediction rules for pneumonia, and might be a useful indication for chest radiography or empiric antibiotic therapy when the diagnosis of pneumonia is in doubt.
Journal ArticleDOI
Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States
Ben J. Metcalf,Sopio Chochua,Robert E. Gertz,Zhongya Li,Hollis Walker,T. Tran,Paulina A. Hawkins,Anita Glennen,Ruth Lynfield,Y. Li,Lesley McGee,Bernard Beall,Art Reingold,S. Brooks,H. Randel,Lisa Miller,B. White,Deborah Aragon,Meghan Barnes,J. Sadlowski,Sue Petit,Matthew L. Cartter,C. Marquez,M. Wilson,Monica M. Farley,Stepy Thomas,Amy Tunali,W. Baughman,Lee H. Harrison,J. Benton,T. Carter,Rosemary Hollick,K. Holmes,A. Riner,Corinne Holtzman,Richard Danila,K. MacInnes,Karen Scherzinger,Kathy Angeles,Joseph Bareta,L. Butler,S. Khanlian,R. Mansmann,Megin Nichols,Nancy M. Bennett,S. Zansky,S. Currenti,Suzanne McGuire,Ann Thomas,M. Schmidt,Jamie Thompson,Tasha Poissant,William Schaffner,Brenda Barnes,K. Leib,K. Dyer,L. McKnight,R. Gierke,Olivia Almendares,J. Hudson,L. McGlone,Gayle Fischer Langley +61 more
TL;DR: WGS-based antimicrobial phenotype prediction was an informative alternative to BDT for invasive pneumococci and correctly predicted penicillin-binding protein types and common resistance determinants.